BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8359568)

  • 1. Octreotide in dumping and short bowel syndromes.
    Farthing MJ
    Digestion; 1993; 54 Suppl 1():47-52. PubMed ID: 8359568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome.
    Richards WO; Geer R; O'Dorisio TM; Robarts T; Parish KL; Rice D; Woltering G; Abumrad NN
    J Surg Res; 1990 Dec; 49(6):483-7. PubMed ID: 2263084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The place of octreotide in the medical management of the dumping syndrome.
    Scarpignato C
    Digestion; 1996; 57 Suppl 1():114-8. PubMed ID: 8813487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome.
    Geer RJ; Richards WO; O'Dorisio TM; Woltering EO; Williams S; Rice D; Abumrad NN
    Ann Surg; 1990 Dec; 212(6):678-87. PubMed ID: 2256759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of peptide hormone ligands for the treatment of dumping and short bowel syndrome.
    Wauters L; Vanuytsel T
    Curr Opin Pharmacol; 2018 Dec; 43():118-123. PubMed ID: 30273889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome.
    Hasler WL; Soudah HC; Owyang C
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1359-65. PubMed ID: 8667198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential indications for octreotide in gastroenterology: summary of workshop.
    Burroughs AK; Malagelada R
    Digestion; 1993; 54 Suppl 1():59-67. PubMed ID: 8359570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide improves early dumping syndrome potentially through incretins: a case report.
    Sato D; Morino K; Ohashi N; Ueda E; Ikeda K; Yamamoto H; Ugi S; Yamamoto H; Araki S; Maegawa H
    Endocr J; 2013; 60(7):847-53. PubMed ID: 23708181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. An update.
    Lamers CB; Bijlstra AM; Harris AG
    Dig Dis Sci; 1993 Feb; 38(2):359-64. PubMed ID: 8425449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of nonendocrine gastrointestinal disorders with octreotide acetate.
    Woltering EA; O'Dorisio TM; Williams ST; Lebrado L; Fletcher WS
    Metabolism; 1990 Sep; 39(9 Suppl 2):176-9. PubMed ID: 1976212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide in the treatment of the dumping syndrome.
    Primrose JN
    Digestion; 1990; 45 Suppl 1():49-58; discussion 58-9. PubMed ID: 2335268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging indications for octreotide therapy, Part 2.
    Mosdell KW; Visconti JA
    Am J Hosp Pharm; 1994 May; 51(10):1317-30. PubMed ID: 8085570
    [No Abstract]   [Full Text] [Related]  

  • 13. [Somatostatin analog (octreotide) in clinical use: current and potential indications].
    Meier R; Dierdorf R; Gyr K
    Schweiz Med Wochenschr; 1992 Jun; 122(25):957-68. PubMed ID: 1621078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of octreotide on gastric and small bowel motility in patients with gastroparesis.
    Edmunds MC; Chen JD; Soykan I; Lin Z; McCallum RW
    Aliment Pharmacol Ther; 1998 Feb; 12(2):167-74. PubMed ID: 9692691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cimetidine on gastric acid secretion and fractional emptying in short bowel syndrome.
    Murphy JP; King DR; Dubois A
    Surg Forum; 1978; 29():423-4. PubMed ID: 401211
    [No Abstract]   [Full Text] [Related]  

  • 16. Long acting somatostatin analogue in dumping syndrome.
    Tulassay Z; Tulassay T; Gupta R; Cierny G
    Br J Surg; 1989 Dec; 76(12):1294-5. PubMed ID: 2691013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy.
    Primrose JN; Johnston D
    Br J Surg; 1989 Feb; 76(2):140-4. PubMed ID: 2702445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open trial of octreotide long-acting release in the management of short bowel syndrome.
    Nehra V; Camilleri M; Burton D; Oenning L; Kelly DG
    Am J Gastroenterol; 2001 May; 96(5):1494-8. PubMed ID: 11374688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal motility considerations in patients with short-bowel syndrome.
    Scolapio JS; Camilleri M; Fleming CR
    Dig Dis; 1997; 15(4-5):253-62. PubMed ID: 9359015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The action of octreotide in dumping syndrome].
    Hölscher AH
    Z Gastroenterol; 1990 Sep; 28 Suppl 2():45-9. PubMed ID: 2281705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.